

Cover Story
Free
By Paul Goldberg and Matthew Bin Han Ong
José Baselga has resigned from his position as physician-in-chief and chief medical officer of Memorial Sloan Kettering Cancer Center less than a week after The New York Times and ProPublica reported that he had failed to disclose his conflicts of interest in scientific and medical journals and at professional meetings.
In Brief


Funding Opportunities
Clinical Roundup


Drugs & Targets
Trending Stories
- OMB proposed rule could end 50% of currently active clinical trials, Stand up for Science analysis finds
- What NHS-Galleri taught us—and what it didn’t
- The NHS-Galleri trial has and will continue to provide critical insights to refine future MCED studies
- Is psilocybin heading to a cancer clinic near you?
Reversing Nixon-era taboo, Trump orders FDA to fast-track psychedelics and ARPA-H to fund research - Ian Krop named section chief of Medical Oncology and Hematology and deputy director for Clinical Affairs at Yale
- FDA clears a way for dramatic reduction in animal toxicology studies in cancer














